Navigation Links
Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution
Date:12/13/2010

PHILADELPHIA, Dec. 13, 2010 /PRNewswire-FirstCall/ -- Innovative Clinical Solutions, Ltd. (Pink Sheets: ICSN) has announced that, in accordance with its plan of liquidation approved by its shareholders on September 22, 2007, its sole Director has approved a second and final liquidating cash distribution (the "Final Liquidating Distribution") in the amount of $0.039251 per share of its outstanding common stock.  The Final Liquidating Distribution will have a record date of December 9, 2010, a payment date of December 16, 2010, and an ex-dividend date of December 17, 2010.  The stock transfer books of the Company will be closed as of December 16, 2010.  The Company will make no further distributions beyond the Final Liquidating Distribution.  There is no requirement for stockholders to surrender shares in connection with the Final Liquidating Distribution.  

An "ex-dividend date" is the date on which a security is traded without a previously declared dividend or distribution.  The timing of the Company's ex-dividend date is determined in accordance with the FINRA rule applicable to such distributions, because the amount of the distribution exceeds 25% of the Company's share value.  Between the record date of December 9, 2010, and the ex-dividend date of December 17, 2010, the stock will trade with due bills reflecting the seller's obligation to transfer the distribution to the buyer.  The due bill redeemable date is December 21, 2010.  

Upon payment of the Final Liquidating Distribution, the Company will have made liquidating distributions (including the first partial liquidating cash distribution made on June 30, 2008, and the Final Liquidating Distribution) in the aggregate amount of $2,990,755, or $0.249251 per share of the Company's common stock.  

Safe Harbor

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements regarding the timing and amounts available for distributions to holders of the Company's common stock.  Such statements reflect the Company's current expectations with respect to future events and are based on its current assumptions and information currently available.  Actual results may differ materially.  There can be no assurance that the Company's expectations will be achieved.  These forward looking statements are neither promises nor guarantees.  The Company undertakes no responsibility to revise or update and such forward-looking statements.  


'/>"/>
SOURCE Innovative Clinical Solutions, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ActiveHealth Management to Deliver Innovative NuVal™ Nutritional Scoring System Through Health Website
2. Chilean Companies Show Innovative Solutions
3. Top Business School Students From Around the World Compete for Innovative Solutions to the Global Clean Water Crisis
4. FDA Launches Initiative to Develop Innovative External Defibrillators
5. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
6. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
7. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
8. CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
9. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
10. Results of Innovative Clinical Study Show New Combination for Weight Loss Success
11. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... is a revolutionary new product that relieves painful carpal tunnel syndrome ... affects more than 8 million people a year. Women suffer from ... methods of treating CTS are painful surgery, the use of NSAIDs ... ... a clear patch worn on the palm of the hand. It ...
(Date:7/11/2017)... 11, 2017  Sysmex America, Inc., a leading ... equipment as well as middleware information systems technology, ... make quality assurance easier and more risk free ... known for the innovation that it delivers to ... quality assurance processes to a new level with ...
(Date:7/10/2017)... July 10, 2017  BDI Group subsidiary Pathway ... support services organization serving specialty pharmacies, home infusion ... of four significant, value-added member programs designed to ... manage reimbursement and improve access and affordability for ... Pathway ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... ... in National Harbor, MD. This year's theme focuses on the new ISO/IEC 17025 ... for quality and integrity in testing and calibration will be changed. , ...
(Date:7/24/2017)... Houston, TX (PRWEB) , ... July 24, 2017 , ... ... group of the nation’s top level plastic surgeons, invited to attend Allergan’s recent meeting ... top 10 most valued companies in the world, Allergan is bringing a newly defined ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... CURE announced that they have enrolled over 100,000 children in their treatment program. ... born every year in areas where treatment is limited or non-existent. Without intervention, ...
(Date:7/24/2017)... ... July 24, 2017 , ... Right ... future. , The agency is hammering out a game plan to implement changes ... laws ever to affect FDA-regulated firms. The new law:, , ...
(Date:7/24/2017)... ... July 24, 2017 , ... “The Perfect Gift”: a customizable and interactive Bible study guide for ... is a born-again Christian. She has always accepted Christ as her Savior, yet never ... was in the Spirit when she wrote this book to her children, so they would ...
Breaking Medicine News(10 mins):